Loading calculators...
Fetching calculator categories and tools for this section.
Preparing tools and content for you. This usually takes a second.
Fetching calculator categories and tools for this section.
Score perimenopause and menopause symptoms with an 11-item checklist (0–3 each, total 0–33): hot flashes, sleep, mood, brain fog, aches, palpitations, GSM, and more. Get a burden band for your clinician visit—not the Menopause Rating Scale (MRS), not a diagnosis. Explore more medical calculators.
Last updated: June 4, 2026
Total score
13 / 33
Moderate burden—many people benefit from structured evaluation and targeted options.
This range commonly prompts discussion of menopausal hormone therapy (MHT) eligibility, non-hormonal prescriptions, cognitive-behavioral therapy for vasomotor symptoms, and genitourinary treatments.
Visit-prep tips
Not medical advice. Chest pain, fainting, stroke symptoms, suicidal thoughts, or heavy bleeding need urgent care—not score interpretation. This tool does not replace the validated MRS or clinical diagnosis of menopause.
0 / 33
Minimal burden
8 / 33
Mild burden
13 / 33
Moderate burden
33 / 33
High burden
| Total score | Band | Meaning on this page |
|---|---|---|
| 0–5 | Minimal | Occasional or mild bother in few domains |
| 6–12 | Mild | Noticeable symptoms—track and discuss at routine visit |
| 13–22 | Moderate | Multi-domain burden—structured evaluation often helpful |
| 23–33 | High | Frequent/severe across domains—prioritize clinician visit |
total = sum of 11 items (each 0–3); max = 33
| Domain | Items | Clinical teaching |
|---|---|---|
| Vasomotor | Hot flashes, night sweats | Estrogen decline lowers thermoregulatory set point; also rule out infection, hyperthyroidism, medications |
| Sleep & fatigue | Insomnia, low energy | Night sweats fragment sleep; overlap with sleep apnea, depression, and anemia |
| Mood & cognition | Low mood, anxiety, brain fog | Perimenopause mood symptoms overlap GAD and MDD—screen broadly, not from one score |
| Somatic | Joint/muscle aches, skin/hair changes | Inflammatory and collagen changes; differentiate autoimmune and thyroid disease |
| Cardiac symptoms | Palpitations, chest discomfort | Can be benign vasomotor-adjacent but cardiac red flags need urgent evaluation |
| Genitourinary (GSM) | Vaginal dryness, urinary urgency/leaks | Genitourinary syndrome of menopause—local estrogen, moisturizers, pelvic floor rehab |
| Stage | Definition | Labs (when used) |
|---|---|---|
| Perimenopause | Irregular cycles ± vasomotor/mood symptoms; can last years | FSH may fluctuate—clinical picture dominates |
| Menopause | 12 months without a period (natural) or surgical/oophorectomy | FSH often elevated; not required for diagnosis when history clear |
| Postmenopause | Years after final menstrual period—GSM and bone risks accumulate | Bone density, lipids per age/risk |
| Aspect | MRS (validated) | This calculator |
|---|---|---|
| Purpose | Validated research/clinic scale (11 items, licensed context) | Original 11-domain 0–3 teaching composite |
| Scoring | Weighted MRS total with published norms | Simple sum 0–33 with arbitrary teaching bands |
| Use | Trials, some specialty clinics | Visit prep and health literacy only |
| Condition | Clues to consider |
|---|---|
| Hypothyroidism / hyperthyroidism | Weight change, cold/heat intolerance, palpitations |
| Major depression or anxiety disorder | Anhedonia, panic, functional decline beyond hot flashes |
| Obstructive sleep apnea | Snoring, witnessed apneas, daytime sleepiness |
| Anemia or B12 deficiency | Exertional dyspnea, paresthesias, heavy bleeding history |
| Medication effects | SSRIs, tamoxifen, GnRH agonists, steroids |
| Primary ovarian insufficiency | Symptoms before age 40—needs specialist workup |
| Option | Teaching notes |
|---|---|
| Menopausal hormone therapy (MHT) | Most effective for vasomotor symptoms in eligible patients; uterus needs progestin strategy; timing and risk discussion with clinician |
| Non-hormonal prescriptions | SSRIs/SNRIs (e.g. paroxetine, venlafaxine), gabapentin, fezolinetant (where available)—for hot flashes when MHT not suitable |
| CBT for vasomotor symptoms | Evidence-based behavioral approaches reduce bother and sleep disruption for some |
| Local GSM therapies | Vaginal estrogen, moisturizers, lubricants, pelvic floor physical therapy for dryness and urinary symptoms |
| Lifestyle & sleep hygiene | Cooling layers, exercise, CBT-I principles, limit alcohol/caffeine—adjunct, not replacement when severe |
Each of 11 symptom groups is rated 0–3 for bother in the past few weeks. The tool sums scores (maximum 33) and maps the total to minimal (0–5), mild (6–12), moderate (13–22), or high (23–33) teaching bands. Thresholds are not validated clinical decision rules. A higher total means more domains are bothersome—not automatic hormone therapy eligibility.
Hot flashes 2, sleep 2, fatigue 2, plus seven domains at 1 and palpitations 0 → sum 13.
Result: 13 / 33 — Moderate burden band.
This range commonly prompts discussion of menopausal hormone therapy (MHT) eligibility, non-hormonal prescriptions, cognitive-behavioral therapy for vasomotor symptoms, and genitourinary treatments.
Share for midlife health literacy and visit prep.
Suggested hashtags: #Menopause #WomensHealth #Perimenopause #MedEd #Calculator